Articles Tagged With:
-
EDs, Community Partners Play Central Role in Slashing HIV Diagnoses in San Francisco
Emergency providers have played a strong role in helping San Francisco drastically reduce the number of new HIV infections as part of the city’s Getting to Zero initiative. In particular, the ED at Zuckerberg San Francisco General Hospital (ZSFGH) has identified 10% of all new HIV infections in the city. Working in partnership with Ward 86, the nation’s first HIV clinic, these patients and their partners have been connected to care quickly, greatly diminishing subsequent transmissions. It is a model that has been duplicated across the city to great effect.
-
As Cannabis Use Proliferates, Investigators Probe What Brings Patients to the ED With Adverse Drug Events
Investigators are beginning to unearth important findings from a rich data set regarding cannabis-related ED visits at a large, academic medical center in Colorado. As states move to legalize recreational and/or medicinal cannabis use, the information is important to helping frontline providers understand how to recognize and treat such patients.
-
Pilot Program in Pennsylvania Prompts EDs to Invest in Care Coordination
A more pronounced focus on care coordination is taking shape in the EDs at a cadre of rural hospitals that are participating in Pennsylvania’s new global budgeting pilot. The pilot is designed to provide a more secure revenue stream to hospitals that have been operating at a loss or with very small operating margins. However, it also signals a strong shift away from the traditional focus on volume toward value-based care and population health.
-
Hospital Case Management Wants to Hear From You
Take five minutes to complete our annual survey.
-
Annual User Survey
-
Relias Media Honored With Multiple Awards
Trio of honors includes first-time recognition for two products.
-
Why Is the QRS Wide?
The ECG in the figure belongs to an older woman who called EMS because of new-onset chest pain. How might one interpret the tracing? Why is the QRS complex wide?
-
Erdafitinib Tablets (Balversa)
Erdafitinib is the first FDA-approved targeted therapy for metastatic bladder cancer.
-
The Promise and Perils of the Apple Heart Study
A large study with virtual enrollment of Apple Watch users helped illustrate the positive predictive value of wearable, pulse-based atrial fibrillation detection technology, as well as the ability to enroll and follow huge numbers of research subjects in a short period.
-
How Safe Are New Medications for Type 2 Diabetes?
In recent years, new medications have been approved for the management of type 2 diabetes, generally after metformin is given. The FDA has reported 55 cases of Fournier’s gangrene in patients using SGLT2 inhibitors. These medications may not be worth the risk when lifestyle alternatives are available.